Your browser doesn't support javascript.
loading
Dual Role of Glutathione as a Reducing Agent and Cu-Ligand Governs the ROS Production by Anticancer Cu-Thiosemicarbazone Complexes.
Ritacca, Alessandra G; Falcone, Enrico; Doumi, Iman; Vileno, Bertrand; Faller, Peter; Sicilia, Emilia.
Afiliação
  • Ritacca AG; Department of Chemistry and Chemical Technologies, Università della Calabria, Ponte P. Bucci, 87036 Arcavacata di Rende (CS), Italy.
  • Falcone E; Institut de Chimie (UMR 7177), University of Strasbourg - CNRS, 4 Rue Blaise Pascal, 67000 Strasbourg, France.
  • Doumi I; Institut de Chimie (UMR 7177), University of Strasbourg - CNRS, 4 Rue Blaise Pascal, 67000 Strasbourg, France.
  • Vileno B; Institut de Chimie (UMR 7177), University of Strasbourg - CNRS, 4 Rue Blaise Pascal, 67000 Strasbourg, France.
  • Faller P; Institut de Chimie (UMR 7177), University of Strasbourg - CNRS, 4 Rue Blaise Pascal, 67000 Strasbourg, France.
  • Sicilia E; Institut Universitaire de France (IUF), 1 rue Descartes, 75231 Paris, France.
Inorg Chem ; 62(9): 3957-3964, 2023 Mar 06.
Article em En | MEDLINE | ID: mdl-36802558
ABSTRACT
α-Pyridyl thiosemicarbazones (TSC) such as Triapine (3AP) and Dp44mT are a promising class of anticancer agents. Contrary to Triapine, Dp44mT showed a pronounced synergism with CuII, which may be due to the generation of reactive oxygen species (ROS) by Dp44mT-bound CuII ions. However, in the intracellular environment, CuII complexes have to cope with glutathione (GSH), a relevant CuII reductant and CuI-chelator. Here, aiming at rationalizing the different biological activity of Triapine and Dp44mT, we first evaluated the ROS production by their CuII-complexes in the presence of GSH, showing that CuII-Dp44mT is a better catalyst than CuII-3AP. Furthermore, we performed density functional theory (DFT) calculations, which suggest that a different hard/soft character of the complexes could account for their different reactivity with GSH.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tiossemicarbazonas / Antineoplásicos Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tiossemicarbazonas / Antineoplásicos Idioma: En Ano de publicação: 2023 Tipo de documento: Article